Press Releases
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
Impella 5.5 and Impella CP are the first left-sided, minimally invasive temporary mechanical circulatory support options for pediatric patients with symptomatic ADHF and cardiogenic shock
